Horse Chestnut: Haemorrhoids, Bruising and Topical Use

Long before anyone ran a trial on leg swelling, horse chestnut was used for complaints that share the same underlying idea: blood vessels that are swollen, leaky or fragile. Haemorrhoids are swollen veins. Bruises are blood that has leaked out of damaged vessels into the tissue. Swelling after a knock or an operation is fluid that has leaked out of capillaries. All of these have attracted horse chestnut preparations — bark wines and tinctures in old French practice, creams and gels in modern European pharmacies, and injectable aescin in hospital medicine in some countries.

The evidence behind these uses is much thinner and more uneven than for chronic venous insufficiency. This page sorts it by type: what rests on tradition and regulatory acceptance of long use, what rests on reviews and small studies, and what has simply never been tested.


Table of Contents

  1. The Common Thread: Leaky and Swollen Vessels
  2. Haemorrhoids
  3. Bruises and Haematomas
  4. Creams and Gels for Heavy Legs
  5. A Multi-Ingredient Cream for Venous Ulcers
  6. Oral Extract and Leg Ulcers
  7. Swelling After Surgery and Injury
  8. Aescin in Stocking Fabric
  9. Topical Safety
  10. Evidence Ledger for These Uses
  11. Key Research Papers
  12. Connections

The Common Thread: Leaky and Swollen Vessels

The proposed actions of aescin, horse chestnut's main saponin, are described in reviews as anti-oedematous (reducing leakage of fluid from small vessels), anti-inflammatory and venotonic (firming the vein wall). A 2001 review by Sirtori describes these properties as well supported in animal models and reports clinically significant activity in chronic venous insufficiency, haemorrhoids and swelling after surgery. A 2019 review by Gallelli adds that both oral aescin and a gel applied to the skin have shown efficacy in blunt trauma injuries as well as in chronic venous insufficiency.

Those are the claims. The sections below look at what stands behind each one. The mechanism itself is covered on Aescin: How It Works.

Back to Table of Contents

Haemorrhoids

Haemorrhoids are cushions of blood vessels in the anal canal that can swell, bleed, itch and ache. Because they are veins under pressure, venoactive products have been tried for them for a long time.

Tradition. The European Medicines Agency's 2012 assessment report on horse chestnut bark records bark preparations for haemorrhoids in older French practice, including a medicinal wine and a tincture, and lists current traditional-use indications for haemorrhoidal symptoms in France and Spain. The same report found no clinical studies or case reports on the efficacy of the bark: "Only the use in folk medicine is mentioned in published literature."

Reviews. Sirtori's 2001 review states that aescin has shown "satisfactory evidence for a clinically significant activity" in haemorrhoids, among other conditions.

What is missing. No randomised controlled trial of horse chestnut for haemorrhoids is among the records reviewed for this page, and the EU herbal monograph for horse chestnut seed does not list haemorrhoids as an indication. The evidence here is therefore a review statement plus tradition. The flavonoid products in the same venoactive class have their own haemorrhoid literature; see Hesperidin: Veins and Circulation.

Rectal bleeding has many causes besides haemorrhoids, including bowel cancer and inflammatory bowel disease; the Hemorrhoids page covers diagnosis and the established treatments.

Back to Table of Contents

Bruises and Haematomas

A bruise is blood that has escaped from damaged small vessels into the skin and tissue beneath; a haematoma is a larger collection of it. The body clears it over days to weeks.

Regulatory status. The European Medicines Agency accepts topical horse chestnut seed preparations as traditional herbal medicinal products "for relief of signs of bruises, such as local oedema and haematoma". In EU law, a traditional-use registration is based on at least 30 years of medicinal use, including 15 years within the EU, plus plausibility — not on proof of efficacy from trials. The EMA's public summary states that these products may also be applied to the skin in adolescents, and its report states that use for bruises is not recommended below 12 years of age because safety data are insufficient. The summary advises seeing a healthcare provider if symptoms persist for longer than five days.

Products described. The preparations listed in the EMA report include creams containing 50 mg of dry extract per gram and gels containing 32 mg of dry extract per gram, some on the market since at least 1976.

Trials. Gallelli's review reports efficacy of an aescin gel in blunt trauma injuries. The EMA report also describes a 2013 study in which an aescin 10% cream was the comparison treatment after facial cosmetic procedures: of 20 people who used it, seven reported no swelling, five minimal swelling, four slight swelling, three moderate swelling and one severe inflammation. That study was designed to test a different product, so it shows how people did on the cream, not whether the cream beat doing nothing.

Other bruise traditions: Arnica and Comfrey for sprains and bruises.

Back to Table of Contents

Creams and Gels for Heavy Legs

The EMA's traditional-use monograph also covers horse chestnut seed preparations, both oral and applied to the skin, "to relieve symptoms of discomfort and heaviness of legs related to minor venous circulatory disturbances". Its summary suggests consulting a healthcare provider if those symptoms have not improved after two weeks. Again, this registration rests on long-standing use, not on trials of the creams.

This is different from the oral standardised extract for chronic venous insufficiency, which the EMA classes as "well-established use" because there are controlled trials behind it. The trials summarised on Chronic Venous Insufficiency Evidence tested capsules, not creams.

Back to Table of Contents

A Multi-Ingredient Cream for Venous Ulcers

A 2009 Italian multicentre study enrolled 80 people with venous leg ulcers. Forty were treated with compression alone and forty with compression plus a "lymph-draining" cream. The cream contained many ingredients: plant extracts of hops, ivy, horse chestnut, grape vine and butcher's broom, plus allantoin, Centella asiatica and hyaluronic acid. The authors reported faster pain relief, less inflammation, faster growth of healing tissue and lesion healing within four weeks in the cream group, and described these differences as statistically significant.

Three limits apply. The abstract does not describe how patients were allocated or whether anyone was blinded. The cream contained so many active ingredients that no effect can be attributed to horse chestnut. And the comparison was against compression alone, not against an identical cream without the herbal extracts. The authors themselves credited the hops and ivy with pain relief and the horse chestnut, grape vine and butcher's broom with the anti-inflammatory action, which is their interpretation rather than something the design could test.

Back to Table of Contents

Oral Extract and Leg Ulcers

The oral extract has been studied in ulcers once in the records reviewed here. A 2006 economic analysis by Leach and colleagues used data from a 12-week randomised, placebo-controlled trial in 54 people with venous ulcers cared for by a South Australian district nursing service. Adding the extract to standard dressings and compression was calculated to save an average of AUD 95 in organisational costs and AUD 10 in dressings per patient, mostly through less frequent dressing changes. The abstract does not report how many ulcers healed. A 2025 review that graded venoactive drugs for ulcer healing gave its top grade to other agents, not horse chestnut.

Back to Table of Contents

Swelling After Surgery and Injury

Swelling after operations or trauma is where injected aescin is used. A 2008 paper reports that sodium β-aescin is approved under China's national drug standard and used clinically for brain swelling and for swelling caused by trauma or surgery. Sirtori's review likewise lists post-operative oedema as an area of clinically significant activity.

These uses involve an injected hospital drug, not a herbal product. The EMA report records that a kidney-failure concern arose with high intravenous doses after heart surgery, and that three follow-up clinical studies in 83 people found no kidney impairment at the doses tested. The 2008 paper also proposed aescin for Bell's palsy, a facial nerve paralysis; that was a hypothesis with no patient data.

Back to Table of Contents

Aescin in Stocking Fabric

An inventive idea combines horse chestnut with the treatment it is often compared with. A 2017 chemistry study investigated loading aescin into cyclodextrins — ring-shaped sugar molecules that can hold other molecules inside them — as a technical route to building aescin into the fabric of stockings. The study found that the larger γ-cyclodextrin is the best host for aescin. It was a laboratory and computer-modelling study; it did not test a stocking on anyone's legs.

Back to Table of Contents

Topical Safety

The EMA lists skin hypersensitivity reactions — itching and redness — as the undesirable effects of topical use, with frequency unknown. The EU monograph's warnings for the creams and gels state that they are not for use on broken skin, around the eyes or on mucous membranes, and that a doctor be consulted if symptoms worsen or signs of skin infection appear. For the heavy-legs indication, it adds inflammation of the skin, thrombophlebitis, hardening under the skin, severe pain, ulcers, sudden swelling of one or both legs, and heart or kidney insufficiency as situations for a doctor.

The EMA report found no new safety issues for oral or skin use when it screened the EU adverse-reaction database in 2018. It also notes that horse chestnut seed extract has no restriction on its use in cosmetics in the EU cosmetic-ingredient database.

Applying a cream to the skin is a very different exposure from eating raw seeds; the hazards of the raw plant are on Raw Seed Poisoning and Esculin.

Back to Table of Contents

Evidence Ledger for These Uses

Back to Table of Contents

Key Research Papers

  1. Sirtori CR. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacological research. 2001;44(3):183-93. PubMed PMID: 11529685
  2. Gallelli L. Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties. Drug design, development and therapy. 2019;13():3425-3437. PubMed PMID: 31631970
  3. Chiummariello S, De Gado F, Monarca C, et al.. [Multicentric study on a topical compound with lymph-draining action in the treatment of the phlebostatic ulcer of the inferior limbs]. Il Giornale di chirurgia. 2009;30(11-12):497-501. PubMed PMID: 20109380
  4. Leach MJ, Pincombe J, Foster G. Using horsechestnut seed extract in the treatment of venous leg ulcers: a cost-benefit analysis. Ostomy/wound management. 2006;52(4):68-70, 72-4, 76-8. PubMed PMID: 16636364
  5. Gloviczki ML, Kakkos SK, Urbanek T, et al.. The role of venoactive compounds in the treatment of chronic venous disease. Journal of vascular surgery. Venous and lymphatic disorders. 2025;13(5):102258. PubMed PMID: 40348378
  6. Liu J, Li Y, Yuan X, et al.. Sodium beta-aescin may be an effective therapeutic agent for Bell's palsy. Medical hypotheses. 2008;71(5):762-4. PubMed PMID: 18762387
  7. Ramos AI, Vaz PD, Braga SS, et al.. Association of aescin with β- and γ-cyclodextrins studied by DFT calculations and spectroscopic methods. Beilstein journal of nanotechnology. 2017;8():348-357. PubMed PMID: 28890859
  8. Zheng Q, Wang T, Wang S, et al.. The anti-inflammatory effects of saponins from natural herbs. Pharmacology & therapeutics. 2025;269():108827. PubMed PMID: 40015518
  9. Bencsik T, Balázs VL, Farkas Á, et al.. Herbal drugs in chronic venous disease treatment: An update. Fitoterapia. 2024;179():106256. PubMed PMID: 39419127
  10. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. The Cochrane database of systematic reviews. 2012;11(11):CD003230. PubMed PMID: 23152216

PubMed Topic Searches

  1. PubMed: topical aescin gel
  2. PubMed: escin and haemorrhoids
  3. PubMed: aescin, haematoma and bruising

Other Sources

Back to Table of Contents

Connections

Back to top